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Graft-versus-host disease (GVHD) is a rare complication after kidney transplantation. We describe a 62-year-old female with 
end-stage renal disease due to hypertension. She received a kidney with 4 mismatched human leukocyte antigen (HLA) out 
of 6 HLA - A, B, DR from a deceased donor. After the procedure, the patient showed watery diarrhea on postoperative day 
(POD) 45. An endoscopic biopsy of the colon revealed some apoptotic cells consistent with GVHD. Thrombocytopenia was 
gradually developed on POD 54. She received steroid pulse therapy, and thrombocytopenia did not progress. However, 
pneumonia, renal failure, and cardiac failure occurred. She died due to multiple organ failure. We must consider GVHD in 
renal transplant recipients without homozygous or identical HLA, who had only watery diarrhea without other typical 
GVHD symptoms such as skin rash and fever, although GVHD is rare in renal transplant recipients.
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INTRODUCTION
Graft-versus-host disease (GVHD) is a lethal complica-
tion after solid organ transplantation [1]. Mortality rate 
was reported more than 75% [2]. The diagnosis is often de-
layed because the early signs such as skin rash, fever, diar-
rhea or liver dysfunction are mistaken for drug reactions 
or infections [3]. Later, the patients develop pancytopenia 
which is the most frequent cause of death [1]. 
A number of GVHD cases have been reported to occur 
in small bowel and liver transplant recipients, with in-
cidence rate of 1 to 2% [4]. However, GVHD has rarely 
been reported as a complication of kidney transplantation. 
In the review of the literatures, GVHD after kidney trans-
plantation has occurred in only three cases. We describe 
GVHD in renal transplant recipient who had 4 mis-
matched human leukocyte antigen (HLA) out of 6 HLA - 
A, B, DR from a deceased donor.
CASE REPORT
The patient was 62-year-old Korean female with 
end-stage renal disease due to hypertension requiring 3 
years of peritoneal dialysis. She had received two HLA 
matched, deceased donor kidney transplant from 
35-year-old male with pontine hemorrhage. The blood 
type of the patient was AB positive and she had no pan-GVHD after kidney transplantation
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Fig. 1.  Colonic biopsy specimen 
from patient shows acute graft 
versus host disease (GVHD). 
GVHD of the colon characterized 
rare intraepithelial lymphocytes in
the absence of substantial inflam-
mation, extensive crypt destruc-
tion in the lamina propria (A), and 
apoptotic cells (arrow) (B).
el-reactive antibodies before the transplantation. Her 
HLA type was HLA-A: 24,33; B: 44,60; DR: 4,-. The donor 
was B and DR positive with HLA type of HLA-A: 2,11; B: 
60,51; DR: 4,14. She received immunosuppressive agents 
with 1.5 mg/kg of antithymocyte globulin as induction 
therapy, and was maintained with tacrolimus, mycophe-
nolate mofetil, and methylprednisolone by our usual 
protocol. 
The creatinine serum level steadily decreased, but low-
est creatinine level was 2.5 mg/dL on postoperative day 
(POD) 23. On POD 25, serum creatinine level abruptly in-
creased to 3.0 mg/dL, and we performed renal biopsy. The 
pathologic result revealed no evidence of acute cellular re-
jection, but benign nephrosclerosis consistent with do-
nor’s nephropathy. She discharged on POD 33. 
About two weeks later, she was admitted to our hospital 
for watery diarrhea, abdominal discomfort, general weak-
ness, and poor oral intake. On admission (POD 45), blood 
pressure was 132/79 mmHg, pulse rate 82/min, body tem-
perature 36.1
oC, and respiratory rate 20/min. The physical 
examination revealed chronic ill looking appearance of 
the patient and dehydrated lip, tongue, and skin. 
Abnormal skin rash was not presented in the patient. 
Initial laboratory values showed a white blood cell count 
of 1,210/μL with 8.7% lymphocytes, hemoglobin 6.9 g/dL, 
platelet count 118,000/μL, total bilirubin 0.2 mg/dL 
(normal range, 0.2 to 1.5 mg/dL), blood urea nitrogen 34.1 
mg/dL, serum creatinine 4.64 mg/dL, and C-reactive pro-
tein 0.03 mg/dL (normal range, ＜0.3  mg/dL). Mycophe-
nolic mofetil was discontinued due to watery diarrhea and 
abdominal discomfort. She was conservatively managed 
with bowel rest and parenteral nutritional support.
She went through an evaluation for watery diarrhea. 
The cytotoxicity assay of her stool was negative for 
Clostridium difficile toxin and stool cultures and special 
stains for microorganisms were all negative. Cytomegalo-
virus (CMV) antigenemia assay was also negative. On 
POD 47, gastroduodenoscopy showed multiple erosive le-
sions and normal mucosa in the colon was shown by 
colonoscopy. The work-up failed to demonstrate an in-
fectious etiology of the gastrointestinal symptoms. On 
POD 48, all biopsied tissue from colon demonstrated some 
apoptotic bodies which were consistent with GVHD on 
histologic examination (Fig. 1). At this time, tacrolimus 
was stopped and only methylprednisolone was used. On 
POD 54, thrombocytopenia was gradually developed. She 
received the steroid pulse therapy, and thrombocytopenia 
did not progress. On POD 62, she complained of dyspnea, 
so chest X-ray and chest computed tomography (CT) was 
performed. Chest CT showed multifocal patchy ground- 
glass opacities and peribronchial consolidation, which 
suggested pneumocystis pneumonia or cytomegalovirus 
pneumonia. On POD 63, the patient developed oliguria, 
and serum creatinine gradually increased. Continuous re-
nal replacement therapy was used due to oliguria and 
metabolic acidosis. On POD 64, bronchoscopy showed no 
endobronchial lesions, and no positive findings detected 
in the brochoalveolar lavage. On POD 65, electrocardio-Jong Man Kim, et al.
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Fig. 2. Amelogenin analysis. (A) There are two band peaks in male, the control. (B) Graph of recipient showed only 1 band peak at 104 base
pair.
Table 1. Characteristics of patients who developed graft-versus-host disease after kidney transplantation
Age Race HLA mismatch
Onset time 
(day)
Fever Skin rash Diarrhea Cytopenia Death
Ohtsuka et al. [8]  25 Japanese Donor’s haplotype 
 homozygous
240 ○○ -- -
Smith et al. [3]  20 Caucasian Donor’s haplotype 
 homozygous
145 ○○ - ○○
Kato et al. [9]  27 Japanese One haplotype identical 17 ○○○○-
Kim 62 Korean 4/6 mismatch 48 - - ○○ ○
HLA, human leukocyte antigen.
gram showed ST elevation on lead I-IV. Troponin I was 
9.674 ng/mL (normal range, ＜0.78 mg/dL) and CK-MB 
77.52 ng/mL (normal range, ＜5 mg/dL). Cardiac enzyme 
was abruptly elevated and blood pressure decreased to 
70/40 mmHg. Coronary angiography was preceded for 
evaluation of cardiac disease. Coronary angiography re-
vealed no vascular stenosis and suggested stress-induced 
cardiomyopathy. The patient expired on POD 67 from 
multiple organ failure. Throughout her hospital course, 
she received transfusion several times with blood prod-
ucts which were either leukocyte reduced or irradiated.
DISCUSSION
 GVHD is the consequence of an immunologic reaction 
of engrafted lymphoid cells against the tissues of the host 
[4]. GVHD is mainly associated with allogenic hema-
topoietic stem cell transplantation, and occurs much less 
frequently after transplantation of immunologically ac-
tive solid organs such as liver and small intestine. Four 
cases of GVHD after kidney transplantation were reported 
including the present case.
Typical symptoms and signs of GVHD were skin rash, 
severe diarrhea, and the elevation of total bilirubin, but 
these findings were often attributed by drug reactions or 
infections. These may make the delay of GVHD diagnosis. 
These clinical presentations occur when donor T lympho-
cytes transferred with the graft are activated by alloanti-
gens expressed by host antigen presenting cells, which ini-
tiate an immune response against recipient tissues such as 
skin, bone marrow, and gastrointestinal tract. Specific 
tests have been used in diagnosis of GVHD. One is de-
tection of macrochimerism which was defined as more GVHD after kidney transplantation
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than 1% donor nucleated cells in the peripheral blood of 
recipient, and the other is single-tandem repeat (STR) 
DNA analysis which quantifies relative amounts of differ-
ent DNA in a single tissue sample. We did not use these 
methods due to several limitations. Much lymphocyte tis-
sue from the donor is required for the detection of macro-
chimerism, but we could not acquire lymphoid tissue due 
to donor being deceased and STR DNA analysis could not 
also be use in our hospital. 
We tested donor-derived Y chromosome detection after 
the patient died. The serum of blood could not be sepa-
rated since the sample was from the dead, so we examined 
DNA which was taken from endoscopic biopsy specimen. 
The amount of DNA was 10 ng/mL. We tested for amelo-
genin assay which shows two band peaks at 104 base pair 
(bp) and 110 bp in man (Fig. 2), meaning donor-derived Y 
chromosome [5,6]. However, the DNA of the recipient 
showed only 1 band peak at 104 bp in amelogenin gene 
assay. The test did not show the evidence of donor-derived 
Y chromosome in the recipient. 
The diagnosis of GVHD is based on the characteristic 
clinical presentations, histological proof of target tissue 
damage and molecular manifestation of invasion of recipi-
ent target tissue by donor T cells. Our case showed the typ-
ical clinical manifestations and histologic confirmation of 
GVHD.
The characteristics of patients who developed GVHD 
after kidney transplantation were summarized in Table 1. 
Donor HLA homozygosity was known as a risk factor for 
GVHD. Donors’ haplotype were homozygous in two cases 
and one case was one haplotype identical. Our case was 
4/6 mismatch. Onset time of GVHD in our case was 48 
days, which is shorter than that of other 2 cases despite 
more HLA mismatch. In addition, the typical signs of 
GVHD such as skin rash and fever were not presented in 
our case. 
Usually, the outcome of GVHD is overwhelming sepsis, 
marrow aplasia, and multiple organ failure. Bacterial in-
fections may be less common due to the use of empiric 
broad-spectrum antibiotics. Antifungal and anti-CMV 
prophylaxis may be indicated because fungi and CMV are 
the most frequent cause of death [7]. However, the in-
cidence of mortality after kidney transplantation was 50% 
(2 cases) in the review of the literatures, including this 
case. The cause of mortality was multiple organ failure 
due to fungal infection or viral infection.
In conclusion, we must consider GVHD in the renal 
transplant recipients with not homozygous or identical 
HLA, who had only watery diarrhea without other typical 
GVHD symptoms such as skin rash and fever, although 
GVHD is rare in renal transplant recipients.
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